gilead hiv - Search News

News

Gilead's bi-annual HIV prevention jab gets FDA approval

USA TODAY on MSN · 8h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Mint on MSN · 4h

Gilead's bi-annual HIV prevention jab gets FDA approval: How much does it cost and how it works? All you need to know…

Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent effectiveness in trials. Here's how it works, and what it costs.

CNBC on MSN · 1d

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

15h

US regulators approve 'miracle’ HIV drug

US regulators approved an HIV drug described as a “miracle” by the UN for its ability to prevent infections with two doses a ...

12h

US approves twice-yearly HIV jab in ‘breakthrough moment’ for fight against Aids

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

2don MSN

Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results